Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy have?
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy has 1,184 citations in the OpenAlex counts ScholarIQ stores.
When was Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy published?
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy has 2017 year in the ScholarIQ index.
What is the open-access status of Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy?
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy has closed oa status in the ScholarIQ index.
What is the DOI of Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy?
The DOI for Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy is on the source record.
What is the PMID of Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy?
The PMID for Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy is on the source record.
What is the OpenAlex record for Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy?
The OpenAlex for Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy is on the source record.